<--GAT-->
Clinical Topics

Melanomas Associated With Internal Malignancy Risk

by U.S. Medicine

January 1, 2019

PALO ALTO, CA — Genetic and environmental risk factors have been associated with the development of multiple primary melanomas (MPM) but a new study questioned whether those patients might have increased predisposition to developing internal malignancies.

The report published in the Journal of the American Academy of Dermatology sought to identify the risk of subsequent malignancies in MPM patients.1

Researchers from the VA Palo Alto, CA, Health Care System and Stanford University Medical Center analyzed multiple primary standardized incidence ratios for patients with one or more, two or more and three or more primary melanomas (PM) in the SEER database from 1973-2014.

Ultimately, they identified 223,799 patients with one or more, 19,709 with two or more and 3,995 with three or more PM, and found that risks of subsequent internal malignancy increased with number of PM, with observed to expected (O/E) ratios of 0.99, 1.14, and 1.23 (p<0.05) for patients with at least one, two and three PM respectively.

The study team reported that Internal malignancy was higher in younger MPM patients and those with superficial spreading melanoma

Most frequent malignancies among MPM patients included breast, prostate, thyroid, soft tissue, brain, kidney, non-Hodgkin’s lymphoma, and chronic lymphocytic leukemia. Results indicated that risk of subsequent cutaneous melanoma increased with O/E ratios of 8.09, to 22.52, to 41.03 (p<0.05) respectively.

While limited by incomplete SEER information about pigmentation phenotypes, histology, and treatments, study authors concluded, “Patients with MPM have increased risk of subsequent internal and cutaneous malignancies and may benefit from tight adherence to age-specific cancer screening.”

1. Cai ED, Swetter SM, Sarin KY. Association of multiple primary melanomas with malignancy risk: a population-based analysis of the Surveillance, Epidemiology, and End Results Program database from 1973-2014. J Am Acad Dermatol. 2018 Oct 1. pii: S0190-9622(18)32637-9. doi: 10.1016/j.jaad.2018.09.027. [Epub ahead of print] PubMed PMID: 30287320.



Related Articles

VAMCs Usually as Good or Better Than Private Hospitals in Same Communities

Veterans are being given more options for obtaining care outside of the VA healthcare system. The question raised in new research is whether doing so improves care.

Report Could Add 23 Presumptive Conditions for Gulf War Veterans

A new report from the National Academies of Sciences, Engineering, and Medicine found that sufficient evidence supported an association between exposure to seven factors and detrimental reproductive effects in men or women who served in the Gulf War or developmental effects in their children.


U.S. Medicine Recommends


More From oncology

Oncology

Some RCC Risk Factors Can Be Modified

Obesity, hypertension and smoking are the three modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma, according to a new study.

Oncology

Better Survival for NSCLC Patients Treated by Military Medicine

Does universal healthcare access provided by the MHS translate into improved patient outcomes for non-small cell lung cancer?

Oncology

Veterans Study Calls for Better Guidance on Lung Cancer Treatment

With increased imaging now detecting lung cancer nodules in sicker patients, a new report suggested that guidelines should be more directive in how to maximize benefit and minimize harm, while taking into account comorbidities and life expectancy.

Oncology

VA/National Cancer Institute Partnership Increases Veteran Access to Trials

Thanks to a new partnership between the National Cancer Institute and the VA, veterans with cancer will now have greater access to potentially lifesaving clinical trials.

Oncology

VA Continues Hepatocellular Screening, but Study Questions the Value

Although a recent study determined that screening veterans with cirrhosis for hepatocellular carcinoma did not reduce the risk of death associated with liver cancer, the VA has no plans to change its screening practices.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up